Connect with us

Health

GSK says tests show Vir antibody drug works against Omicron

GlaxoSmithKline on Thursday said that a pre-clinical analysis of the antibody-based COVID-19 therapy it is developing with US partner Vir has indicated that the drug also works against the new Omicron variant.

Further tests will be carried out on the sotrovimab therapy to firm up the results, GSK said in a statement.

For all the latest headlines follow our Google News channel online or via the app.

Read more:

Moderna exec says company could have Omicron booster ready in March

UAE reports its first case of COVID-19 variant Omicron

Fauci: First US case of COVID-19 omicron variant identified

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Pandemic experts express concern over avian influenza spread to humans

The ongoing global spread of “bird flu” infections to mammals including humans is a significant public health concern, senior UN medics said on Thursday, as they announced new measures to tackle airborne diseases.

Continue Reading

Health

Violations of women’s reproductive health rights trigger rise in preventable deaths

African women are 130 times more likely to die due to pregnancy or childbirth complications than women in Europe and Northern America, the UN sexual and reproductive health agency (UNFPA) said in a new report published on Wednesday.

Continue Reading

Health

Nigeria first country to introduce ‘revolutionary’ meningitis vaccine

Nigeria has become the first country to roll out a “revolutionary” five-in-one vaccine against meningitis, the World Health Organization (WHO) said in a statement on Friday.

Continue Reading

Trending